Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed EyePoint's target, Goldman cut Sunrun's, B of A lowered Coupang's, BTIG cut Klaviyo's, Jefferies raised J&J Snack Foods', Raymond James raised Select Water Solutions', and Freedom Broker raised Danaos'.
Klaviyo, Similarweb, and Braze have drawn analyst price target boosts or upgrades amid the AI stock correction, with each posting revenue growth and notable upside potential.
Klaviyo (NYSE:KVYO) reported first-quarter revenue growth of 28% year over year and raised its full-year outlook, as executives pointed to momentum in enterprise customers, international markets and artificial intelligence products during the company’s Q1 2026 earnings call.
Co-Founder and Co-CEO A
In a dramatic defiance of the broader market volatility currently plagueing the enterprise software sector, Braze Inc. (NASDAQ: BRZE) saw its shares skyrocket by 19.87% on Wednesday, March 25, 2026. The stock climbed from $18.02 to close at $21.60, marking its strongest single-day performance in over two
By Financial Analyst Team | Published March 26, 2026 Introduction In the rapidly evolving landscape of customer engagement, few companies have demonstrated the resilience and technical agility of Braze Inc. (Nasdaq: BRZE). Long regarded as the "best-of-breed" alternative to legacy marketing clouds, Braze has spent the last decade shifting the paradigm from static, batch-processed emails [...]
In a resounding validation of the "agentic AI" era in marketing technology, Braze (NASDAQ: BRZE) announced on March 24, 2026, that it has officially surpassed the $800 million Annual Recurring Revenue (ARR) milestone. Reporting its fourth-quarter and full-year fiscal 2026 results, the customer engagement leader delivered a significant top-line beat,
